Venter Pharma SL company

Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals. It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively. Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Alcobendas, Madrid, Spain
Founded Date: 2003-01-01
Employees Number: 1-10
Investors Number: 3
Total Funding: €3.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
info@venterpharma.com
Register and Claim Ownership